Literature DB >> 25547609

Galectin-3 is expressed in the myocardium very early post-myocardial infarction.

Satwat Hashmi1, Suhail Al-Salam2.   

Abstract

BACKGROUND: Galectin-3 (GAL-3) plays a regulatory role in several diverse biological processes and disease states. It is associated with heart failure and increased risk of death in a number of studies. We aim to study the direct effects of ischemia on GAL-3 levels in the heart very early in the course of events following myocardial infarction (MI).
METHODS: Male C57B6/J mice were used for permanently ligating the left anterior descending artery of the heart to create ischemia/infarction in the anterior wall of left ventricle (LV). Heart samples were processed for immunohistochemical and immunofluorescent labeling, enzyme-linked immunosorbent assay, and quantitative reverse transcriptase polymerase chain reaction to identify GAL-3 levels in the heart during the first 24 h following MI.
RESULTS: GAL-3 mRNA was significantly increased at 60min (P=.032), 4 h (P=.012), and 24 h (P=.00) post-MI groups in the infarcted LV as compared to sham. Thirty minutes post-MI GAL-3 mRNA is higher than the sham and almost reaching statistical significance (P=.056). GAL-3 protein was significantly increased in the LV at 30 min (P=.021), 60 min (P=.029), 4 h (P=.015), and 24 h (P=.01) post-MI compared to corresponding sham-operated mice. Plasma GAL-3 levels are also significantly raised at 24-h post-MI. GAL-3 is colocalized with cardiomyocytes and endothelial cells in the ischemic area of the LV. GAL-3 is also colocalized with hypoxia-inducible factor-1 alpha (HIF-1α).
CONCLUSIONS: We show for the first time that GAL-3 is increased at both transcriptional and translational levels in the LV in early ischemic period, which can possibly be a part of the prosurvival gene expression profile transcribed by HIF-1α. This is significant because it can help in understanding the mechanism of very early response of the myocardium following acute infarction and help devise ways to save the viable tissue before permanent damage sets in.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Galectin 3; Heart

Mesh:

Substances:

Year:  2014        PMID: 25547609     DOI: 10.1016/j.carpath.2014.12.001

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  18 in total

Review 1.  Immunohistochemical detection of early myocardial infarction: a systematic review.

Authors:  Cristina Mondello; Luigi Cardia; Elvira Ventura-Spagnolo
Journal:  Int J Legal Med       Date:  2016-11-25       Impact factor: 2.686

2.  Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison.

Authors:  Satwat Hashmi; Suhail Al-Salam
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  Multiplex quantitative imaging of human myocardial infarction by mass spectrometry-immunohistochemistry.

Authors:  Aleksandra Aljakna; Estelle Lauer; Sébastien Lenglet; Silke Grabherr; Tony Fracasso; Marc Augsburger; Sara Sabatasso; Aurélien Thomas
Journal:  Int J Legal Med       Date:  2018-03-19       Impact factor: 2.686

Review 4.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

5.  Small Endogeneous Peptide Mitigates Myocardial Remodeling in a Mouse Model of Cardioselective Galectin-3 Overexpression.

Authors:  Swati D Sonkawade; Saraswati Pokharel; Badri Karthikeyan; Minhyung Kim; Shirley Xu; Kristi Kc; Sandra Sexton; Kayla Catalfamo; Joseph A Spernyak; Umesh C Sharma
Journal:  Circ Heart Fail       Date:  2021-08-20       Impact factor: 10.447

6.  Galectin-1: a biomarker of surgical stress in murine model of cardiac surgery.

Authors:  Satwat Hashmi; Suhail Al-Salam
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 7.  Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.

Authors:  Signe Holm Nielsen; Alan J Mouton; Kristine Y DeLeon-Pennell; Federica Genovese; Morten Karsdal; Merry L Lindsey
Journal:  Matrix Biol       Date:  2017-12-14       Impact factor: 11.583

8.  Left ventricular remodeling after the first myocardial infarction in association with LGALS-3 neighbouring variants rs2274273 and rs17128183 and its relative mRNA expression: a prospective study.

Authors:  Ana Djordjevic; Milica Dekleva; Maja Zivkovic; Aleksandra Stankovic; Natasa Markovic Nikolic; Dragan Alavantic; Tamara Djuric
Journal:  Mol Biol Rep       Date:  2018-09-18       Impact factor: 2.316

Review 9.  TAM receptor tyrosine kinase function and the immunopathology of liver disease.

Authors:  S K Mukherjee; A Wilhelm; C G Antoniades
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-11       Impact factor: 4.052

Review 10.  The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review.

Authors:  Simon W Rabkin; Jacky K K Tang
Journal:  Heart Fail Rev       Date:  2021-07       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.